title: Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit.
authors.affiliation: Department of Neurosurgery, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. hsteiner@med.uni-heidelberg.de
authors.forename: Hans Herbert
authors.initials: HH
authors.lastname: Steiner
authors.forename: Matteo Mario
authors.initials: MM
authors.lastname: Bonsanto
authors.forename: Philipp
authors.initials: P
authors.lastname: Beckhove
authors.forename: Michael
authors.initials: M
authors.lastname: Brysch
authors.forename: Karsten
authors.initials: K
authors.lastname: Geletneky
authors.forename: Rezvan
authors.initials: R
authors.lastname: Ahmadi
authors.forename: Rebecca
authors.initials: R
authors.lastname: Schuele-Freyer
authors.forename: Paul
authors.initials: P
authors.lastname: Kremer
authors.forename: Golamreza
authors.initials: G
authors.lastname: Ranaie
authors.forename: Dejana
authors.initials: D
authors.lastname: Matejic
authors.forename: Harald
authors.initials: H
authors.lastname: Bauer
authors.forename: Marika
authors.initials: M
authors.lastname: Kiessling
authors.forename: Stefan
authors.initials: S
authors.lastname: Kunze
authors.forename: Volker
authors.initials: V
authors.lastname: Schirrmacher
authors.forename: Christel
authors.initials: C
authors.lastname: Herold-Mende
mesh_terms: D018109:Avulavirus; D019496:Cancer Vaccines / Q000494:pharmacology*; D016022:Case-Control Studies; D016543:Central Nervous System Neoplasms / Q000276:immunology* / Q000628:therapy*; D005240:Feasibility Studies; D005260:Female; D005909:Glioblastoma / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D007150:Immunohistochemistry; D016233:Immunotherapy, Active; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011379:Prognosis; D015996:Survival Rate; D014407:Tumor Cells, Cultured
chemical_list: D019496:Cancer Vaccines